80_FR_13431 80 FR 13382 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting

80 FR 13382 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 49 (March 13, 2015)

Page Range13382-13382
FR Document2015-05706

Federal Register, Volume 80 Issue 49 (Friday, March 13, 2015) 
[Federal Register Volume 80, Number 49 (Friday, March 13, 2015)]
[Notices]
[Page 13382]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-05706]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health and 
Human Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel; Wellstone Centers for Muscular 
Dystrophy.
    Date: April 27-28, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suite at the Chevy Chase Pavilion, Washington, DC 
20115.
    Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Eunice Kennedy Shriver National 
Institute of Child Health and Human Development, NIH, 6100 Executive 
Boulevard, Room 5B01-G, Bethesda, MD 20892-9304, (301) 435-6878, 
wedeenc@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: March 9, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-05706 Filed 3-12-15; 8:45 am]
BILLING CODE 4140-01-P

13382 Federal Register / Vol. 80, No. 49 / Friday, March 13, 2015 / Notices alternative regulatory approaches, we DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND selected those approaches that would HUMAN SERVICES HUMAN SERVICES maximize net benefits. Based on the analysis that follows, the Department National Institutes of Health Food and Drug Administration believes that these proposed priorities [Docket No. FDA–2015–D–0198] are consistent with the principles in Eunice Kennedy Shriver National Executive Order 13563. Institute of Child Health and Human Current Good Manufacturing Practice We also have determined that this Development; Notice of Closed Requirements for Combination regulatory action would not unduly Meeting Products; Draft Guidance for Industry interfere with State, local, and tribal and Food and Drug Administration governments in the exercise of their Pursuant to section 10(d) of the Staff; Extension of Comment Period governmental functions. Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is AGENCY: Food and Drug Administration, In accordance with both Executive HHS. Orders, the Department has assessed the hereby given of the following meeting. ACTION: Notice; extension of comment potential costs and benefits, both The meeting will be closed to the period. quantitative and qualitative, of this public in accordance with the regulatory action. The potential costs provisions set forth in section 552b(c)(4) SUMMARY: The Food and Drug are those resulting from statutory and 552b(c)(6), Title 5 U.S.C., as Administration (FDA) is extending the requirements and those we have amended. The grant applications and comment period by 30 days to April 29, determined as necessary for the discussions could disclose 2015, for the notice entitled ‘‘Current administering the Department’s confidential trade secrets or commercial Good Manufacturing Practice programs and activities. property such as patentable material, Requirements for Combination The benefits of the Disability and and personal information concerning Products; Draft Guidance for Industry Rehabilitation Research Projects and individuals associated with the grant and Food and Drug Administration Centers Program have been well applications, the disclosure of which Staff; Availability,’’ that appeared in the established over the years. Projects would constitute a clearly unwarranted Federal Register of January 27, 2015 (80 similar to ones envisioned by the invasion of personal privacy. FR 4280). In that document, FDA proposed priorities have been announced the availability of a draft Name of Committee: National Institute of guidance for industry and FDA staff and completed successfully, and the Child Health and Human Development proposed priorities would generate new requested comments. The Agency is Special Emphasis Panel; Wellstone Centers knowledge through research. The new taking this action in response to a for Muscular Dystrophy. DRRPs would generate, disseminate, request for an extension to allow Date: April 27–28, 2015. and promote the use of new information interested persons additional time to Time: 8:00 a.m. to 5:00 p.m. that would improve outcomes for submit comments. Agenda: To review and evaluate grant individuals with disabilities. applications. DATES: FDA is extending the comment Intergovernmental Review: This Place: Embassy Suite at the Chevy Chase period on the draft guidance. Submit program is not subject to Executive Pavilion, Washington, DC 20115. either electronic or written comments Order 12372. Contact Person: Cathy J. Wedeen, Ph.D., by April 29, 2015. Electronic Access to This Document: Scientific Review Officer, Scientific Review ADDRESSES: Submit written requests for The official version of this document is Branch, Eunice Kennedy Shriver National single copies of the draft guidance the document published in the Federal Institute of Child Health and Human document entitled ‘‘Current Good Register. Free Internet access to the Development, NIH, 6100 Executive Manufacturing Practice Requirements official edition of the Federal Register Boulevard, Room 5B01–G, Bethesda, MD for Combination Products’’ to the Office and the Code of Federal Regulations is 20892–9304, (301) 435–6878, wedeenc@mail of Combination Products, Food and available via the Federal Digital System .nih.gov. Drug Administration, 10903 New at: www.gpo.gov/fdsys. At this site you (Catalogue of Federal Domestic Assistance Hampshire Ave., Bldg. 32, Rm. 5129, can view this document, as well as all Program Nos. 93.864, Population Research; Silver Spring, MD 20993–0002. Send other documents of this Department 93.865, Research for Mothers and Children; one self-addressed adhesive label to published in the Federal Register, in 93.929, Center for Medical Rehabilitation assist that office in processing your text or Adobe Portable Document Research; 93.209, Contraception and request. See the SUPPLEMENTARY Format (PDF). To use PDF you must Infertility Loan Repayment Program, National INFORMATION section for electronic have Adobe Acrobat Reader, which is Institutes of Health, HHS) access to the draft guidance document. available free at the site. Dated: March 9, 2015. Submit electronic comments on the draft guidance to http://www. You may also access documents of the Michelle Trout, regulations.gov. Submit written Department published in the Federal Program Analyst, Office of Federal Advisory comments to the Division of Dockets Register by using the article search Committee Policy. Management (HFA–305), Food and Drug feature at: www.federalregister.gov. [FR Doc. 2015–05706 Filed 3–12–15; 8:45 am] Administration, 5630 Fishers Lane, Rm. Specifically, through the advanced BILLING CODE 4140–01–P 1061, Rockville, MD 20852. Identify search feature at this site, you can limit comments with the docket number mstockstill on DSK4VPTVN1PROD with NOTICES your search to documents published by found in brackets in the heading of this the Department. document. Dated: March 3, 2015. FOR FURTHER INFORMATION CONTACT: John Kathy Greenlee, Barlow Weiner, Office of Combination Administrator. Products, Food and Drug [FR Doc. 2015–05333 Filed 3–12–15; 8:45 am] Administration, 10903 New Hampshire BILLING CODE 4154–01–P Ave., Bldg. 32, Rm. 5129, Silver Spring, VerDate Sep<11>2014 19:27 Mar 12, 2015 Jkt 235001 PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 E:\FR\FM\13MRN1.SGM 13MRN1


Document Created: 2015-12-18 11:41:38
Document Modified: 2015-12-18 11:41:38
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesApril 27-28, 2015.
FR Citation80 FR 13382 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR